Winton Group LTD Cassava Sciences Inc Transaction History

Winton Group LTD

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 12, 2021	SELL	$6.79 - $12.25 $299,364 - $540,090	-44,089 Closed	0 $0
Q3 2020 Oct 30, 2020	BUY	$2.86 - $11.51 $35,661 - $143,518	12,469 Added 39.43%	44,089 $507,000
Q2 2020 Aug 05, 2020	BUY	$2.04 - $9.64 $64,504 - $304,816	31,620 New	31,620 $97,000

207

14M

2.98M

6.57M

Ticker SAVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,097,900
Market Cap $110M
Description
Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2b clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's...

Get notified when there are updates to the investment portfolio of Winton Group LTD, based on Form 13F filings with the SEC.

Stay updated on Winton Group LTD with notifications on news.